Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced that its TRIA valves have...

Foldax® Inc., a pioneer in the development of innovative, polymer heart valves, today announced a manufacturing agreement with Dolphin...

Foldax announced completion of enrollment in the Indian clinical trial of the TRIA™ polymer surgical mitral heart valve.

Foldax announced that the first 30 patients have been treated outside of the U.S., in the Indian clinical trial...

Foldax announced that it has executed an agreement with Australia’s national science agency, CSIRO, for full ownership of a...

Foldax Inc. announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective...

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial...

Foldax has announced the presentation of results from the first animal study of its transcatheter valve from the TRIA...

Foldax announced publication of the first clinical results for its TRIA™ biopolymer heart valve - the first polymer valve...

Foldax® announced completion of enrollment in the U.S. early feasibility study of the TRIA™ surgical aortic heart valve. The...